Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 1/20 | 0.58 |
| ▸ | TTR | P02766 | 2/20 | 0.56 |
| ▸ | MAOA | P21397 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.53 |
| ▸ | CASP1 | P29466 | 1/20 | 0.53 |
| ▸ | CASP7 | P55210 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 6/20 | 0.52 |
| ▸ | RAB9A | P51151 | 5/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.48 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22649900 | 1.00 | HCRTR1 (0.58) | HCRTR1TTRMAOAKDM4EALDH1A1 | |
| SCHEMBL22650086 | 0.97 | HCRTR1 (0.55) | HCRTR1TTRMAOAKDM4EALDH1A1 | |
| SCHEMBL22649916 | 0.97 | HCRTR1 (0.55) | HCRTR1TTRMAOAKDM4EALDH1A1 | |
| SCHEMBL22650055 | 0.97 | HCRTR1 (0.55) | HCRTR1TTRMAOAKDM4EALDH1A1 | |
| SCHEMBL24299383 | 0.97 | TTR (0.59) | HCRTR1TTRMAOAKDM4EALDH1A1 | |
| SCHEMBL22649917 | 0.96 | HCRTR1 (0.56) | HCRTR1TTRMAOAKDM4EALDH1A1 | |
| SCHEMBL22650027 | 0.96 | HCRTR1 (0.56) | HCRTR1TTRMAOAKDM4EALDH1A1 | |
| SCHEMBL22650046 | 0.93 | HCRTR1 (0.54) | HCRTR1TTRMAOAKDM4EALDH1A1 | |
| SCHEMBL25073511 | 0.91 | AHR (0.47) | HCRTR1TTRKDM4EALDH1A1CYP3A4 | |
| SCHEMBL23913792 | 0.91 | AHR (0.47) | HCRTR1TTRKDM4EALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873294-B2 | Compound containing anthrone and nitrogen-containing heterocycle and application in OLED devices | JIANGSU SUNERA TECHNOLOGY CO., LTD. (CN) | 2024-01-16 | — | — | US | disclosed |
| US-11873294-B2 | Compound containing anthrone and nitrogen-containing heterocycle and application in OLED devices | JIANGSU SUNERA TECHNOLOGY CO., LTD. (CN) | 2024-01-16 | — | — | US | disclosed |
| US-20200354347-A1 | Compound containing anthrone and nitrogen-containing heterocycle and application in OLED devices | VALIANT CO., LTD. (CN) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354347-A1 | Compound containing anthrone and nitrogen-containing heterocycle and application in OLED devices | NLRP1, OCIAD2, OCIAD1 | HCRTR1 671/4885TTR 2196/4885MAOA 189/4885 |
| US-11873294-B2 | Compound containing anthrone and nitrogen-containing heterocycle and application in OLED devices | NLRP1, OCIAD2, OCIAD1 | HCRTR1 671/4885TTR 2196/4885MAOA 189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.